Processa Pharmaceuticals, Inc. - FORM S-1 - EX-10 - November 14, 2012

Attached files

file filename
EX-3 - Processa Pharmaceuticals, Inc.heatwurx32amendedbylaws2.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx1013leaseagreement.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx107votingagreement.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx109subordinatednote.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx102gilesperformanceo.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx104formofpledgeagree.htm
EX-3 - Processa Pharmaceuticals, Inc.heatwurx31thirdamendedandres.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx101seniorsecurednote.htm
EX-10 - Processa Pharmaceuticals, Inc.fheatwurx103investorsrightsa.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx108subordinatedsecur.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx1011formofstockoptio.htm
EX-2 - Processa Pharmaceuticals, Inc.heatwurx21assetpurchaseagree.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx10102011equityincent.htm
EX-14 - Processa Pharmaceuticals, Inc.heatwurx141code_ofethicsandb.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx106rightoffirstrefus.htm
EX-10 - Processa Pharmaceuticals, Inc.heatwurx105gilesconsultingag.htm
EX-23 - Processa Pharmaceuticals, Inc.heatwurx232heinopinionconsen.htm
S-1 - Processa Pharmaceuticals, Inc.heatwurx_forms1edgarfinal1.htm

HEATWURXS, INC.

GRANT NOTICE



Granted:  


Grantee:


Address:


Status with the Company:

Employee/Officer/Director/Consultant


Type of Option:

ISO/NQSO


No. of Shares:


Option Price:


Expiration Date:

Five years from date of grant


Vesting Schedule:

 


By your signature and the signature of the Company’s representative below, you and the Company agree that this option is granted under and governed by the terms and conditions of the Amended and Restated 2011 Equity Incentive Plan and the Stock Option Agreement, both of which are attached to and made a part of this document.


Optionee:

Heatwurx, Inc.



                                                    

By:

 

                                                    

Title:

Print Name




Processa Pharmaceuticals, Inc. Reports